In the face of multiplying epidemics across the continent (Dengue, Mpox, Yellow Fever, etc.), Mali is hosting, on April 7, 2026, the launch of the ambitious project « Strengthening Clinical and Genomic Research Capacities on Arboviruses » (SC-CRA). This strategic initiative aims to place African expertise at the heart of regional health security VIDEO. Professor Diakité, Rector of the University of Sciences,…
On Tuesday, April 7, 2026, our country hosted the official launch of the « Strengthening Clinical and Genomic Research Capacities on Arboviruses » (SC-GRA) project. The event took place under the auspices of the Ministry of Higher Education and Scientific Research, with key representatives from the health sector in attendance. This sub-regional project, which I have the honor of chairing, will span…
A delegation from the WACCREP, composed of Mr. Cheick Oumar Tangara, and the MEAL Officer, Dr. Mountaga Diallo from Mali, participated in the Science for Africa Foundation’s EPSILON project workshop for Program and Monitoring, Evaluation, Accountability, and Learning (MEAL) officers, held in Lagos from November 24 to 28, 2025. During this five-day workshop, the team presented a WACCREP project titled…
TThe 4th International Conference on Public Health in Africa (CPHIA 2025) opened on 22 October 2025, at the Durban International Convention Center in South Africa, launching a four-day convening under the theme: “Moving Towards Self-Reliance to Achieve Universal Health Coverage and Health Security in Africa.” The conference that spotlights African-led innovations, policy solutions, and research aimed at building resilient, self-reliant…
Dr. Joseph Antoine Boré from Guinea was invited to the University of Liberia (UL) to share their experiences on filovirus studies with our fellow researcher colleagues at the Pacific Institute for Research and Evaluation (UL-PIRE). A great thank you to Dr Kennedy for this collaboration between CRAM and UL-PIRE. WACCREP Communication Office
ABSTRACT rVSVΔG-ZEBOV-GP and Ad26.ZEBOV, MVA-BN-Filo are WHO-prequalified vaccination regimens against Ebola virus disease (EVD). Challenges associated with measuring long-term clinical protection warrant the evaluation of immune response kinetics after vaccination. READ MORE
https://docs.google.com/forms/d/e/1FAIpQLSf3F35qb3zX08rNPogEjL5FhjjoFKS92Knpe3Mrb3UxLU6yxw/viewform

